UK-headquartered start-up Tenpoint Therapeutics has reeled in a commendable $70 million in first-round financing that will be used to develop its cell-based therapies for sight-robbing diseases. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

You can have the latest and greatest crossbow on the market and it won’t do you a bit of good if you can’t put the arrow where you want it—which is where a crossbow scope comes in. The best one will ...

More recently, though, pharmaceutical and biotech companies have been offering alternatives in the form of drops that essentially shrink the pupil and improve near or intermediate focus. Those drops — ...